MaxCyte Appoints Ali Soleymannezhad as Chief Commercial Officer
ROCKVILLE, Md., Oct. 10, 2024 ( GLOBE NEWSWIRE ) -- MaxCyte, Inc., ( Nasdaq: MXCT. LSE: MXCT ) , a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and ...
| Ticker |
Sentiment |
Impact |
|
MXCT
|
Somewhat Bullish
|
35 %
|
|
TOSCF
|
Neutral
|
8 %
|
